[go: up one dir, main page]

NO20055211L - Anti-fungale forbindelser og fremgangsmater for anvendelse - Google Patents

Anti-fungale forbindelser og fremgangsmater for anvendelse

Info

Publication number
NO20055211L
NO20055211L NO20055211A NO20055211A NO20055211L NO 20055211 L NO20055211 L NO 20055211L NO 20055211 A NO20055211 A NO 20055211A NO 20055211 A NO20055211 A NO 20055211A NO 20055211 L NO20055211 L NO 20055211L
Authority
NO
Norway
Prior art keywords
fungal
methods
fungal compounds
agents
compounds
Prior art date
Application number
NO20055211A
Other languages
English (en)
Norwegian (no)
Other versions
NO20055211D0 (no
Inventor
Takumi Kawabe
Hidetaka Kobayashi
Original Assignee
Canbas Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Canbas Co Ltd filed Critical Canbas Co Ltd
Publication of NO20055211D0 publication Critical patent/NO20055211D0/no
Publication of NO20055211L publication Critical patent/NO20055211L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N37/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids
    • A01N37/44—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids containing at least one carboxylic group or a thio analogue, or a derivative thereof, and a nitrogen atom attached to the same carbon skeleton by a single or double bond, this nitrogen atom not being a member of a derivative or of a thio analogue of a carboxylic group, e.g. amino-carboxylic acids
    • A01N37/46—N-acyl derivatives
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02—Local antiseptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06191—Dipeptides containing heteroatoms different from O, S, or N
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0827—Tripeptides containing heteroatoms different from O, S, or N
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1027—Tetrapeptides containing heteroatoms different from O, S, or N
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/18—Testing for antimicrobial activity of a material

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Epidemiology (AREA)
  • Wood Science & Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Environmental Sciences (AREA)
  • Dentistry (AREA)
  • Plant Pathology (AREA)
  • Pest Control & Pesticides (AREA)
  • Agronomy & Crop Science (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Dermatology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Toxicology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Pain & Pain Management (AREA)
NO20055211A 2003-04-07 2005-11-04 Anti-fungale forbindelser og fremgangsmater for anvendelse NO20055211L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US46110903P 2003-04-07 2003-04-07
US10/819,375 US7125842B2 (en) 2003-04-07 2004-04-05 Anti-fungal compounds and methods of use
PCT/IB2004/001523 WO2004089396A2 (fr) 2003-04-07 2004-04-07 Composes antifongiques et leurs procedes de mise en oeuvre

Publications (2)

Publication Number Publication Date
NO20055211D0 NO20055211D0 (no) 2005-11-04
NO20055211L true NO20055211L (no) 2006-01-05

Family

ID=33162249

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20055211A NO20055211L (no) 2003-04-07 2005-11-04 Anti-fungale forbindelser og fremgangsmater for anvendelse

Country Status (8)

Country Link
US (1) US7125842B2 (fr)
EP (1) EP1613339A2 (fr)
JP (1) JP4728220B2 (fr)
KR (1) KR20060010742A (fr)
AU (1) AU2004228783A1 (fr)
CA (1) CA2521713A1 (fr)
NO (1) NO20055211L (fr)
WO (1) WO2004089396A2 (fr)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040109853A1 (en) * 2002-09-09 2004-06-10 Reactive Surfaces, Ltd. Biological active coating components, coatings, and coated surfaces
US20100210745A1 (en) * 2002-09-09 2010-08-19 Reactive Surfaces, Ltd. Molecular Healing of Polymeric Materials, Coatings, Plastics, Elastomers, Composites, Laminates, Adhesives, and Sealants by Active Enzymes
US20050058689A1 (en) * 2003-07-03 2005-03-17 Reactive Surfaces, Ltd. Antifungal paints and coatings
US20090238811A1 (en) * 2002-09-09 2009-09-24 Mcdaniel C Steven Enzymatic Antimicrobial and Antifouling Coatings and Polymeric Materials
US20100233146A1 (en) * 2002-09-09 2010-09-16 Reactive Surfaces, Ltd. Coatings and Surface Treatments Having Active Enzymes and Peptides
JP4705567B2 (ja) * 2003-06-25 2011-06-22 株式会社 キャンバス 免疫調整活性、抗炎症活性、および抗ウイルス活性を有するペプチドおよびペプチド模倣物
US8618066B1 (en) 2003-07-03 2013-12-31 Reactive Surfaces, Ltd., Llp Coating compositions having peptidic antimicrobial additives and antimicrobial additives of other configurations
JP2008505908A (ja) * 2004-07-06 2008-02-28 ファーム ソリューションズ インコーポレイテッド 殺虫、殺ダニ、および殺真菌の組み合わせ活性を有する多機能組成物
US20060153786A1 (en) * 2004-12-10 2006-07-13 Talima Therapeutics, Inc. Compositions and methods for treating conditions of the nail unit
GB0428136D0 (en) * 2004-12-22 2005-01-26 Syngenta Participations Ag Novel materials and methods for the production thereof
US20060286006A1 (en) * 2005-06-21 2006-12-21 Mcdaniel C S Method and apparatus for the treatment of fluid waste streams
WO2007002120A2 (fr) * 2005-06-23 2007-01-04 Duke University Effet fongicide obtenu par regulation des voies de transduction du signal
JP4994618B2 (ja) * 2005-08-11 2012-08-08 学校法人北里研究所 Ｔｓ−１／カンプトテシン類による化学放射線療法
GB0702020D0 (en) * 2007-02-02 2007-03-14 Novabiotics Ltd Peptides and their use
LT2178549T (lt) * 2007-07-26 2017-01-25 Revance Therapeutics, Inc. Antimikrobinis peptidas ir jo kompozicijos
TW201000116A (en) * 2008-05-14 2010-01-01 Takeda Pharmaceutical Peptide compound and use thereof
EP2647287A1 (fr) * 2008-08-01 2013-10-09 Dow AgroSciences LLC Utilisation de 5-fluorocytosine et ses dérivés en tant que fongicides
US8388904B1 (en) 2008-12-22 2013-03-05 Reactive Surfaces, Ltd., Llp Equipment decontamination system and method
US20100283445A1 (en) * 2009-02-18 2010-11-11 Freescale Semiconductor, Inc. Integrated circuit having low power mode voltage regulator
US8319548B2 (en) * 2009-02-18 2012-11-27 Freescale Semiconductor, Inc. Integrated circuit having low power mode voltage regulator
SG179021A1 (en) * 2009-09-15 2012-04-27 Reactive Surface Ltd Anti-fouling paints and coatings
WO2011056561A1 (fr) 2009-10-27 2011-05-12 Beth Israel Deaconess Medical Center Procédés et compositions pour la génération et l'utilisation d'anticorps spécifiques à une conformation
US8400819B2 (en) * 2010-02-26 2013-03-19 Freescale Semiconductor, Inc. Integrated circuit having variable memory array power supply voltage
CN103379826A (zh) * 2010-12-16 2013-10-30 陶氏益农公司 5-氟胞嘧啶和其它杀真菌剂的协同性杀真菌相互作用
US8537625B2 (en) 2011-03-10 2013-09-17 Freescale Semiconductor, Inc. Memory voltage regulator with leakage current voltage control
US10487114B2 (en) 2011-04-27 2019-11-26 Beth Israel Deaconess Medical Center, Inc. Methods for administering peptides for the generation of effective c/s conformation-specific antibodies to a human subject in need thereof
US9035629B2 (en) 2011-04-29 2015-05-19 Freescale Semiconductor, Inc. Voltage regulator with different inverting gain stages
CN104395388A (zh) 2012-02-17 2015-03-04 安德森公司 含有聚乳酸的建筑构件
US9726663B2 (en) 2012-10-09 2017-08-08 The Procter & Gamble Company Method of identifying or evaluating synergistic combinations of actives and compositions containing the same
CN104704362B (zh) 2012-10-09 2018-08-28 宝洁公司 鉴定或评估有益活性物质的方法以及包含其的组合物
US9144538B2 (en) 2013-02-08 2015-09-29 The Procter & Gamble Company Cosmetic compositions containing substituted azole and methods for alleviating the signs of photoaged skin
US9138393B2 (en) 2013-02-08 2015-09-22 The Procter & Gamble Company Cosmetic compositions containing substituted azole and methods for improving the appearance of aging skin
EP3013351B1 (fr) * 2013-06-24 2019-10-30 CanBas Co., Ltd. Peptides et peptidomimétiques utilisés en association avec des traitements pour sous-populations de patients atteints de cancer
KR20170054190A (ko) * 2015-11-09 2017-05-17 (주)앰틱스바이오 진균 감염 치료 및 예방을 위한 신규한 키나아제 및 이들의 용도
KR102068470B1 (ko) * 2017-12-21 2020-01-22 대한민국 항진균 및 항염증 활성을 갖는 신균주 아쓰리니움 js0567 및 이의 용도
WO2020037270A1 (fr) * 2018-08-17 2020-02-20 Cepheid Procédés de décontamination d'acides nucléiques
AU2019320825B2 (en) 2018-08-17 2025-09-25 Cepheid Methods and compositions for nucleic acid isolation

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5486503A (en) * 1991-11-01 1996-01-23 The Trustees Of Boston University Anti-fungal histatin-based peptides
US5889148A (en) * 1995-07-06 1999-03-30 Mogam Biotechnology Research Institute Antibiotic peptides
JPH11116597A (ja) * 1997-10-15 1999-04-27 Morinaga Milk Ind Co Ltd ペプチド誘導体および抗真菌剤
JP2000197499A (ja) * 1998-10-27 2000-07-18 Pola Chem Ind Inc 新規化合物及びその製造法
DE60019318T2 (de) * 1999-09-22 2006-03-09 Canbas Co., Ltd., Numazu Zusammensetzungen und verfahren zur inhibierung vom zellulären g2-übergang und sensitisierung von zellen gegen dna-schädigenden wirkstoffe
JP3472821B2 (ja) * 2000-12-08 2003-12-02 広島大学長 新規ペプチド、及び当該ペプチドを用いた組成物
KR100863090B1 (ko) * 2002-01-17 2008-10-13 다케다 파머수티컬 컴패니 리미티드 항증식 활성을 지니고／지니거나 핵산 손상제 또는 처리제를 증강시키는 펩티드 및 펩티드모방체

Also Published As

Publication number Publication date
EP1613339A2 (fr) 2006-01-11
KR20060010742A (ko) 2006-02-02
WO2004089396A2 (fr) 2004-10-21
US7125842B2 (en) 2006-10-24
AU2004228783A1 (en) 2004-10-21
NO20055211D0 (no) 2005-11-04
JP2007527852A (ja) 2007-10-04
US20040229801A1 (en) 2004-11-18
JP4728220B2 (ja) 2011-07-20
CA2521713A1 (fr) 2004-10-21
WO2004089396A3 (fr) 2005-01-06

Similar Documents

Publication Publication Date Title
NO20055211L (no) Anti-fungale forbindelser og fremgangsmater for anvendelse
NO20083324L (no) Multisykliske aminosyrederivater og anvendelse derav
NO20053201L (no) Nye heterocykliske fluorglukosidderivater, legemidler inneholdende disse forbindelser og deres anvendelse.
NO20082476L (no) Bicykliske forbindelser med kinaseinhiberende aktivitet
CY1111225T1 (el) Νεα πεπτιδια ως αναστολεις πρωτεασης νs3-σερινης ιου ηπατiτιδας c
CR9365A (es) Compuestos y metodos para la inhibicion de la protein-cinasa raf
ECSP088425A (es) INHIBIDORES DE LA ACTIVIDAD Akt
EA200600620A1 (ru) Набор для ингаляции с ингаляционным порошком, содержащим тиотропий
NO20080061L (no) Imidazolyl-pyrimidinforbindelser for anvendelse til behandling av proliferative lidelser
BRPI0510617A (pt) uso de expressão de il-17 para prever inflamação de pele; processos de tratamento
CO5700767A2 (es) Procedimiento de tratamiento de rechazo de transplantes
NO20073487L (no) Valg av pasienter for terapi med en HER-inhibitor
NO20074295L (no) Substituerte gamma lactamer som terapeutiske midler
NO20061722L (no) Nye GLP-1 derivater
ATE464303T1 (de) Als inhibitoren von rock und anderen proteinkinasen geeignete zusammensetzungen
NO20083153L (no) Kjemiske forbindelser
ECSP077180A (es) Compuestos, composiciones y métodos
DE502006002198D1 (de) Ur erhöhung der permeabilität von unterirdischen, teinsformationen und zum lösen von carbonatischen und/oder carbonathaltigen verunreinigungen bei der erdölförderung
BRPI0516727A (pt) métodos para tratar um linfoma positivo em cd30 , para inibir o crescimento de uma célula que expressa cd30, e para tratar ou prevenir uma doença
NO20062649L (no) Biarylsulfonamider og metoder for anvendelse av disse
NO20072290L (no) Organiske forbindelser.
CY1108540T1 (el) Ταυτοποιηση θεραπευτικων ενωσεων
NO20073113L (no) Indenylderivater og anvendelse derav for behandling av neurologiske lidelser
ECSP055575A (es) Uso de derivados de tio-oxindol en el tratamiento de enfermedades de la piel.
ATE464307T1 (de) Mif-hemmer

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application